Contributor Since 2011
The following is excerpted from a research report we originally published for subscribers on 12-Jan-12. It is based on data we routinely acquire from the United States Securities and Exchange Commission under the Freedom of Information Act. This particular report warns of the risk of undisclosed SEC investigative activity in the companies noted below. The full report of 12-Jan-12 is attached.Undisclosed SEC Investigative Activity
Jefferies Group Inc. (JEF)- $14.62 Mkt. Cap.- $2.9 B) New SEC Data Point Re-affirms Risk of Involvement in an Undisclosed SEC Investigation. In a letter dated 28-Sep-11, the SEC confirmed that this company was somehow involved in an active and ongoing investigation that appeared undisclosed at the time. In a letter dated 11-Jan-12, we received new information from the SEC suggesting, again, this company was involved in unspecified SEC investigative activity. We continue to find no disclosure of the same as of this date.
Medifest Inc. (MED)- $15.78 Mkt. Cap.- $244 mm) Possible, Undisclosed SEC Investigation. In a letter dated 6-Jan-12, we received information from the SEC suggesting this company was involved in unspecified SEC investigative activity. We found no disclosure of the same as of this date.
Full report here.